SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-035651
Filing Date
2021-07-06
Accepted
2021-07-06 06:07:04
Documents
3
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea143733-6k_alteritytherap.htm 6-K 11405
2 NOTICE UNDER SECTION 708A (5) OF CORPORATION ACT ea143733ex99-1_alteritythe.htm EX-99.1 7320
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4588
  Complete submission text file 0001213900-21-035651.txt   26284
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 211072387
SIC: 2834 Pharmaceutical Preparations